Cleared Traditional

K213424 - Jabra Enhance Plus (FDA 510(k) Clearance)

Class II Ear, Nose, Throat device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
90d
Days
Class 2
Risk

K213424 is an FDA 510(k) clearance for the Jabra Enhance Plus. Classified as Self-fitting Air-conduction Hearing Aid, Prescription (product code QDD), Class II - Special Controls.

Submitted by GN Hearing A/S (Ballerup, DK). The FDA issued a Cleared decision on January 19, 2022 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.3325 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ear, Nose, Throat review framework, consistent with the majority of Class II 510(k) submissions.

View all GN Hearing A/S devices

Submission Details

510(k) Number K213424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 2021
Decision Date January 19, 2022
Days to Decision 90 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 89d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QDD Self-fitting Air-conduction Hearing Aid, Prescription
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.3325
Definition A Self-fitting Air-conduction Hearing Aid Is A Wearable Sound Amplifying Device That Is Intended To Compensate For Impaired Hearing And Incorporates Technology, Including Software, That Allows Users To Program Their Hearing Aids. This Technology Integrates User Input With A Self-fitting Strategy And Enables Users To Independently Derive And Customize Their Hearing Aid Fitting And Settings. This Is A Prescription Hearing Aid.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ear, Nose, Throat devices follow this clearance model.

Regulatory Peers - QDD Self-fitting Air-conduction Hearing Aid, Prescription

Devices cleared under the same product code (QDD) and FDA review panel - the closest regulatory comparables to K213424.
Lumen 155-SF
K223911 · Intricon Corporation · Oct 2023
Vibe SF Self-Fitting Hearing Aid
K220403 · Wsaud A/S · Aug 2022
MDHearingAid app, MDHearingAid Smart hearing aids
K220303 · Mdhearingaid · Aug 2022
BHA100 Series Braun Clear Hearing Aid
K212609 · Kaz USA, Inc., A Helen of Troy Company · Jan 2022
Bose SoundControl Hearing Aids
K211008 · Bose Corporation · May 2021